The use of antiangiogenic agents can counteract the immunosuppressive effects of vascular endothelial growth factor (VEGF), regulate the tumor vascular system by activating effector T cells, and enhance immune cell infiltration, thereby achieving synergistic effects [12]. This evidence concerns the gene VEGFA and neoplasm.